Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pattern Recognition of Immune Cells in Atopic Dermatitis Patients Receiving Dupilumab

NCT05098821 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT05098821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05098821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pattern Recognition of Immune Cells in Atopic Dermatitis Patients Receiving Dupilumab
Lead sponsor
Charite University, Berlin, Germany
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2019
Completion date
December 31, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis